ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - January 1920

Decade

Year

Issue

September 2022, Vol 158, No. 9, Pages 980-1088

Editorial

Antibiotic Stewardship in Dermatology—Reducing the Risk of Prolonged Antimicrobial Resistance in Skin

Abstract Full Text
JAMA Dermatol. 2022;158(9):989-991. doi:10.1001/jamadermatol.2022.3168

More Than Skin Deep—Understanding the Lived Experience of Acne

Abstract Full Text
JAMA Dermatol. 2022;158(9):991-992. doi:10.1001/jamadermatol.2022.2741
Original Investigation

Absolute and Relative Risk of New-Onset Psoriasis Associated With Tumor Necrosis Factor-α Inhibitor Treatment in Patients With Immune-Mediated Inflammatory Diseases: A Danish Nationwide Cohort Study

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):997-1004. doi:10.1001/jamadermatol.2022.2360

This cohort study investigates the associated risk between new-onset psoriasis and tumor necrosis factor-α inhibitor treatment compared with nonbiologic conventional treatment.

Projective Personification Approach to the Experience of People With Acne and Acne Scarring—Expressing the Unspoken

Abstract Full Text
open access has audio
JAMA Dermatol. 2022;158(9):1005-1012. doi:10.1001/jamadermatol.2022.2742

This qualitative study examines how patients with facial and truncal acne or acne scars relate to their condition personification exercise.

Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):1013-1021. doi:10.1001/jamadermatol.2022.2878

This cost-utility analysis evaluates the cost-effectiveness of rituximab biosimilars vs mycophenolate mofetil as a first-line steroid-sparing agent for moderate to severe pemphigus vulgaris.

Clinicophotobiological Characterization of Photoaggravated Atopic Dermatitis

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):1022-1030. doi:10.1001/jamadermatol.2022.2823

This case series study evaluates clinical and photobiological characteristics of photoaggravated atopic dermatitis.

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):1031-1039. doi:10.1001/jamadermatol.2022.2749

This randomized clinical trial of hypericin ointment, 0.25%, for patients with early-stage mycosis fungoides−cutaneous T-cell lymphoma examines lesion response rates and adverse events to determine the efficacy and safety of this novel photodynamic therapy.

Effect of Prior Diagnoses on Dermatopathologists’ Interpretations of Melanocytic Lesions: A Randomized Controlled Trial

Abstract Full Text
free access has audio
JAMA Dermatol. 2022;158(9):1040-1047. doi:10.1001/jamadermatol.2022.2932

This randomized controlled trial measures the extent to which dermatopathologists’ diagnoses are influenced by receiving prior diagnostic information from another dermatopathologist.

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):1048-1056. doi:10.1001/jamadermatol.2022.3014

This cohort study describes the drug survival of dupilumab in patients with atopic dermatitis and identifies associated predictors.

Brief Report

Kidney–Urinary Tract Involvement in Intermediate Junctional Epidermolysis Bullosa

Abstract Full Text
JAMA Dermatol. 2022;158(9):1057-1062. doi:10.1001/jamadermatol.2022.2885

This case series study characterizes the natural history and genotype-phenotype correlations of kidney–urinary tract manifestations in a cohort of German patients with intermediate junctional epidermolysis bullosa.

Images in Dermatology

Cutaneous Blastomycosis

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(9):1064. doi:10.1001/jamadermatol.2022.3151

This case report describes a verrucous oval plaque with central atrophy on the right thigh.

Cutaneous Anthrax

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(9):1065. doi:10.1001/jamadermatol.2022.3216

This case report describes a 1-year-old boy who was brought to the pediatric emergency department with complaints of a painless reddish skin lesion on the left buttock for 7 days.

JAMA Dermatology Clinicopathological Challenge

Firm Red-Brown Plaques in a Patient With Systemic Scleroderma

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(9):1066-1067. doi:10.1001/jamadermatol.2022.3241

A man in his 60s with systemic sclerosis complicated by scleroderma kidney crisis, heart failure, interstitial lung disease, sclerodactyly, and Raynaud phenomenon presented with a pruritic rash. What is your diagnosis?

Multiple Skin-Colored Subcutaneous Nodules in a Girl

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(9):1068-1069. doi:10.1001/jamadermatol.2022.3248

A 2-year-old child presented with skin-colored subcutaneous nodules that developed 40 days after birth, starting on the left foot and progressing to the face, trunk, and extremities and distal interphalangeal joint deformity of both hands. What is your diagnosis?

JAMA Dermatology Patient Page

Vulvar Lichen Sclerosus

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):1088. doi:10.1001/jamadermatol.2022.0359

This Patient Page describes the symptoms, diagnosis, and treatment of vulvar lichen sclerosus.

Research Letter

Evaluation of Gabapentin and Transforaminal Corticosteroid Injections for Brachioradial Pruritus

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):1070-1071. doi:10.1001/jamadermatol.2022.2376

This case series compares the reported outcomes of transforaminal injections and oral medications in patients with a brachioradial pruritus diagnosis.

Analysis of Content and Phrasing of Health-Related Quality-of-Life Patient-Reported Outcome Measures Used in Patients With Acne

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):1072-1073. doi:10.1001/jamadermatol.2022.2293

This qualitative study examines patient-reported outcome measures used in the treatment of patients with acne.

Cutaneous T-Cell–Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination

Abstract Full Text
free access has active quiz
JAMA Dermatol. 2022;158(9):1073-1076. doi:10.1001/jamadermatol.2022.2383

This case series study describes cutaneous T-cell–rich lymphoid infiltrates characterized by papulonodules on the trunk and/or extremities in 6 patients after receiving the Pfizer/BioNTech COVID-19 mRNA vaccine.

Incidence and Treatment of Actinic Keratosis in Older Adults With Medicare Coverage

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):1076-1078. doi:10.1001/jamadermatol.2022.2555

This cohort study evaluates 10 years of Medicare claims data for outpatient encounters related to actinic keratosis.

Observation

Improvement of Facial Discoid Dermatosis With Ustekinumab Treatment

Abstract Full Text
JAMA Dermatol. 2022;158(9):1079-1080. doi:10.1001/jamadermatol.2022.2478

This case report describes a woman in her early 40s with a 10-year history of facial rash; multiple well-demarcated, orangish-pink, flat-topped papules; and plaques with fine scale that involved the forehead, cheeks, jawline, and neck.

Xeroradiography as a Noninvasive Tool in Diagnosing Calciphylaxis

Abstract Full Text
JAMA Dermatol. 2022;158(9):1080-1082. doi:10.1001/jamadermatol.2022.2158

This case report describes a women in her 50s with obesity, end-stage kidney disease, and type 2 diabetes who presented with severe painful, erythematous nonhealing ulcerated skin lesions with necrotic eschars on the right lower abdomen.

Comment & Response

Melanoma Overdiagnosis Is Not the Key Problem

Abstract Full Text
JAMA Dermatol. 2022;158(9):1082-1083. doi:10.1001/jamadermatol.2022.2927

Melanoma Overdiagnosis Is Not the Key Problem—Reply

Abstract Full Text
JAMA Dermatol. 2022;158(9):1083-1084. doi:10.1001/jamadermatol.2022.2926
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2022;158(9):980. doi:10.1001/jamadermatol.2021.4224
×